Canada Markets closed

Akero Therapeutics, Inc. (0K4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
18.700.00 (0.00%)
At close: 08:01AM CET
Full screen
Previous Close17.90
Open17.50
Bid17.20 x N/A
Ask17.40 x N/A
Day's Range17.50 - 17.50
52 Week Range15.70 - 28.60
Volume75
Avg. Volume21
Market Cap652.411M
Beta (5Y Monthly)0.50
PE Ratio (TTM)N/A
EPS (TTM)-2.49
Earnings DateMar. 14, 2022 - Mar. 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est54.71
  • Zacks

    Is Akero Therapeutics, Inc. (AKRO) Outperforming Other Medical Stocks This Year?

    Here is how Akero Therapeutics, Inc. (AKRO) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.

  • GlobeNewswire

    Akero Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11 at 10:30 a.m. E.T. A live webcast of the Company presentation will be available through the investor relations section of the Compa

  • GlobeNewswire

    Akero Therapeutics to Present at the Evercore ISI 4th Annual HealthCONx Virtual Conference

    SOUTH SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Virtual Conference on Thursday December 2 at 3:30 p.m. E.T. A live webcast of the Company fireside chat will be available through the investor relatio